AGP Executive Report
Last update: 7 hours agoSwiss Tech & Industry: Temenos commissioned Celent research showing a “switchable middle” in banking: nearly three-quarters of customers are only moderately satisfied or worse, and personalization is the loyalty lever—yet just 4% of banks call it a top priority. Biotech & Pharma: Novartis’ failed Phase 3 pelacarsen (Lp(a)) result adds pressure to the Lp(a) gene-editing race, while Roche signed a backloaded $2B deal with Atavistik Bio to find allosteric small-molecule pockets for cardiometabolic drugs. Robotics & Automation: ETH Zurich spinout ANYbotics added access-controlled door inspection to its ANYmal robots via dormakaba and LEGIC. Climate & Resilience: Allianz Trade estimates Switzerland’s 2026 heatwave cost at CHF 400M and warns of further productivity hits. Research & Science: XENONnT in Italy detected the quietest neutrinos yet, enabling new rare-process studies. Policy & Identity: Switzerland’s Senate backed a move to restrict the Swiss cross on products made abroad, after IPI practice changes. Tech in Switzerland’s orbit: Zurich Summit 2026 spotlights film and AI, with executives gathering at Dolder Grand.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
